244765-00-2

Basic information

• Product Name: ANTHRANILIC ACID, N-BOC-5-HYDROXY
• Synonyms: N-BOC-5-HYDROXYANTHRANILIC ACID;2-[N-(tert-butoxy)forMaMido]-5-hydroxybenzoic acid
• CAS NO: 244765-00-2
• Molecular Formula: C₁₂H₁₅NO₅
• Molecular Weight: 253.25
• Mol File: 244765-00-2.mol

Chemical Properties

• Boiling Point: 385.6°Cat760mmHg
• Flash Point: 187°C
• Appearance: /
• Density: 1.337g/cm³
• Vapor Pressure: 1.23E-06mmHg at 25°C
• Refractive Index: 1.601
• PKA: 3.58±0.36(Predicted)
• CAS DataBase Reference: ANTHRANILIC ACID, N-BOC-5-HYDROXY(CAS DataBase Reference)
• NIST Chemistry Reference: ANTHRANILIC ACID, N-BOC-5-HYDROXY(244765-00-2)
• EPA Substance Registry System: ANTHRANILIC ACID, N-BOC-5-HYDROXY(244765-00-2)

Safety Data

• Hazardous Substances Data: 244765-00-2(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research and Drug Development:
ANTHRANILIC ACID, N-BOC-5-HYDROXY is used as a key building block for the synthesis of peptide and protein-based drugs, as well as in the development of new drug candidates. Its BOC-protected amino acid structure allows for the controlled removal of the protecting group under specific conditions, enabling further chemical reactions and modifications.
Used in Medicinal Chemistry:
ANTHRANILIC ACID, N-BOC-5-HYDROXY is utilized as a versatile compound in medicinal chemistry, providing a foundation for the design and synthesis of novel drug molecules. Its unique chemical properties, including the presence of a 5-hydroxyl group, contribute to its potential applications in various therapeutic areas, such as the development of targeted therapies and the improvement of drug delivery systems.

InChI:InChI=1/C12H15NO5/c1-12(2,3)18-11(17)13-9-5-4-7(14)6-8(9)10(15)16/h4-6,14H,1-3H3,(H,13,17)(H,15,16)

Upstream product

• 60-29-7 diethyl ether 
• 24424-99-5 di-tert-butyl dicarbonate 
• 394-31-0 2-amino-5-hydroxybenzoic acid 

Downstream Products

• 301534-09-8 1-(carbo-t-butoxymethyl)-4-(2-carboethoxyethyl)-7-[(4-amidinophenyl)methyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione, acetate 
• 301534-07-6 1-(carbo-t-butoxymethyl)-4-(2-carboethoxyethyl)-7-[(4-cyanophenyl)methyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione 
• 301534-04-3 N-(carbo-t-butoxymethyl)-5-hydroxyanthranilic acid 
• 74230-08-3 4-hydroxy-2-nitrobenzoic acid 

Relevant articles and documents

Inhibitors of serine proteases, particularly HCV NS3 protease

The present invention relates to compounds, methods and pharmaceutical compositions for inhibiting proteases, particularly serine proteases, and more particularly HCV NS3 proteases. The compounds, and the compositions and methods that utilize them, can be

Benzodiazepine derivatives for imaging thrombi

The invention provides compounds comprising glycoprotein IIb/IIIa receptor-binding benzodiazepine derivatives covalently linked to metal ion chelators. The compounds of the invention may be labeled with a radionuclide such as 99m Tc and used to image thro